These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 26740899

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
    Liegl B, Hornick JL, Corless CL, Fletcher CD.
    Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
    [Abstract] [Full Text] [Related]

  • 3. Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors.
    Kara T, Serinsoz E, Arpaci RB, Gubur O, Orekici G, Ata A, Colak T, Arican A.
    Pathol Res Pract; 2013 Jul; 209(7):413-7. PubMed ID: 23722018
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the Novel Monoclonal Antibody Against DOG1 as a Diagnostic Marker for Gastrointestinal Stromal Tumors.
    Abdel-Hadi M, Bessa SS, Hamam SM.
    J Egypt Natl Canc Inst; 2009 Sep; 21(3):237-47. PubMed ID: 21132034
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. DOG1 is a sensitive and specific immunohistochemical marker for diagnosis of canine gastrointestinal stromal tumors.
    Dailey DD, Ehrhart EJ, Duval DL, Bass T, Powers BE.
    J Vet Diagn Invest; 2015 May; 27(3):268-77. PubMed ID: 25862711
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.
    West RB, Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K, Zhu S, Ball CA, Nielsen TO, Patel R, Goldblum JR, Brown PO, Heinrich MC, van de Rijn M.
    Am J Pathol; 2004 Jul; 165(1):107-13. PubMed ID: 15215166
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The role of the DOG1 antibody in the diagnosis of gastrointestinal stromal tumours - GIST].
    Gutierrez MR, Dorronsoro ML, Marco AM, Pérez IR, Villegas IA, Virseda JM.
    An Sist Sanit Navar; 2011 Jul; 34(2):245-51. PubMed ID: 21904406
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases.
    Kim KH, Nelson SD, Kim DH, Choi KU, Kim SJ, Min KW, Jang KS, Paik SS, Oh YH, Chae SW, Sohn JH, Kim HJ, Cho YK, Kim BI, Park DI, Sohn CI, Oh S, Choi SH, Choi YJ, Woo HY, Park YL, Park SJ, Lee SH, Ryu S, DO SI, Kang G, Kim K, Cho YH, Pyo JS.
    Anticancer Res; 2012 Mar; 32(3):923-37. PubMed ID: 22399613
    [Abstract] [Full Text] [Related]

  • 17. Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations.
    Rizzo FM, Palmirotta R, Marzullo A, Resta N, Cives M, Tucci M, Silvestris F.
    BMC Cancer; 2016 Feb 11; 16():87. PubMed ID: 26867653
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).
    Miettinen M, Sobin LH, Sarlomo-Rikala M.
    Mod Pathol; 2000 Oct 11; 13(10):1134-42. PubMed ID: 11048809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.